MicroPort ScientificMCRPF 69 ROE % is 23.72% as of Dec. 2025. GuruFocus rates MCRPF with a GF Score™ of 69/100 and a GF Value™ of $1.23 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 797 Medical Devices & Instruments companies, MicroPort Scientific ranks better than 62.99% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, MicroPort Scientific's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort Scientific ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort Scientific's ROE % distribution charts can be found below:
* The bar in red indicates where MicroPort Scientific's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
MicroPort Scientific (MCRPF) has a ROE % of 23.72% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on MicroPort Scientific and its competitors. According to the industry distribution chart, MicroPort Scientific ranks #295 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 37%.
Is MicroPort Scientific's ROE % too high?
MicroPort Scientific's current ROE % is 23.72%. The Medical Devices & Instruments industry median ROE % is 2.40. MicroPort Scientific's value of 23.72% is 888.3% above this industry median. Based on the distribution chart, MicroPort Scientific ranks #295 out of 797 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, MicroPort Scientific has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort Scientific's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort Scientific ranks #295 out of 797 companies for ROE %. This puts MicroPort Scientific in the upper half of its industry. The industry median ROE % is 2.40. MicroPort Scientific's value of 23.72% is 888.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroPort Scientific's current ROE % of 23.72% is 888.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on MicroPort Scientific and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort Scientific's current ROE % is 23.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort Scientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort Scientific (MCRPF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.23, compared to a current price of $0.85 — trading 30.7% below its estimated fair value. The current ROE % is 23.72% and 888.3% above the Medical Devices & Instruments industry median of 2.40. MicroPort Scientific's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For MicroPort Scientific (MCRPF), the current ROE % is 23.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort Scientific (MCRPF) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort Scientific stock appears to be undervalued.
The current stock price of $0.85 is trading 30.7% below its estimated GF Value™ of $1.23.
GuruFocus considers MicroPort Scientific to be Possible Value Trap.
Key valuation signals for MCRPF:
ROE %: 23.72%
GF Value™: $1.23 vs. price of $0.85 (30.7% below fair value)
Industry Position: 888.3% above the Medical Devices & Instruments median (#295 of 797)
No single metric tells the full story. See the MCRPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MCRPF has been successfully added to your 
